Dataset features


Application: Gene expression microarray analysis
Number of samples: 71
Release date: Oct 29 2016
Last update date: Feb 22 2018
Access: Public
Diseases: Colorectal Neoplasms, Tumor Lysis Syndrome
Dataset link Apelin, a novel predictive biomarker for bevacizumab response in colorectal cancer

Experimental Protocol

The analysis consisted of 3 batches that were hybridized at 3 different time points. Besides colon tissues, but outside the scope of these analyses, also RNA of whole kidney or liver (metastasis) tissues and cell fractions were hybridized on these arrays. Some replicate samples within and between batches served as technical replicates and as reference within one batch. References for batch 2 were colon tumour bulk 94 and for batch 3 colon tumour bulk 121. Technical replicates were: colon adenocarcinoma 104 (n=2), colon tumour EC 109 (n=2), colon tumour EC 118 (n=2), colon tumour epithelial cells 124 (n=2), kidney normal EC 4 (n=2), kidney tumour EC 4 (n=2), kidney normal EC 5 (n=2), kidney normal EC 6 (n=2), colon normal EC 68 (n=2), kidney normal EC 7 (n=2), colon tumour EC 71 (n=2), liver metastasis 72 (n=2), colon tumour EC 80 (n=2), colon normal EC 81 (n=2), colon normal EC 82 (n=2), colon normal EC 89 (n=2), kidney tumour EC 8II (n=2), kidney normal EC 9 (n=2), colon tumour EC 94 (n=2), colon tumour bulk 99 (n=2), colon tumour EC 99 (n=2), colon tumour bulk 94 (n=3, reference batch 2), colon tumour bulk 121 (n=13, reference batch 3).








Martijn Cordes